Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilitiesCarl M. Gay, Lauren A. Byers, Kavya Ramkumar et al.|Cancer Cell|2021Cited by 930
Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous CarcinomasJoshua D. Campbell, Esther Drill, Christina Yau et al.|Cell Reports|2018Cited by 366
The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancersSamrat T. Kundu, Don L. Gibbons, Lauren A. Byers et al.|Oncogene|2015Cited by 128
The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA networkXiaochao Tan, Jonathan M. Kurie, Priyam Banerjee et al.|Journal of Clinical Investigation|2018Cited by 72
The EMT activator ZEB1 accelerates endosomal trafficking to establish a polarity axis in lung adenocarcinoma cellsPriyam Banerjee, Jonathan M. Kurie, Guan-Yu Xiao et al.|Nature Communications|2021Cited by 64